139 related articles for article (PubMed ID: 2862275)
1. Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors.
Lokhandwala MF; Watkins HO; Sabouni MH; Alkadhi KA
J Pharmacol Exp Ther; 1985 Aug; 234(2):337-44. PubMed ID: 2862275
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.
Lokhandwala MF; Kivlighn SD; Jandhyala BS
J Pharmacol Exp Ther; 1984 Mar; 228(3):696-703. PubMed ID: 6707919
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA1 and DA2 receptor agonists and antagonists.
Sabouni MH; Alkadhi KA; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Jan; 236(1):65-70. PubMed ID: 2867216
[TBL] [Abstract][Full Text] [Related]
4. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
[TBL] [Abstract][Full Text] [Related]
5. Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
Grega GJ; Barrett RJ; Adamski SW; Lokhandwala MF
J Pharmacol Exp Ther; 1984 Jun; 229(3):756-62. PubMed ID: 6144791
[TBL] [Abstract][Full Text] [Related]
6. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
[TBL] [Abstract][Full Text] [Related]
7. Different dopamine receptor subtypes mediate the neurogenic vasodilation produced by fenoldopam and SK & F 85174 in the dog hindlimb.
Lokhandwala MF; Watkins HO; Dlewati A
Eur J Pharmacol; 1987 Nov; 143(3):383-90. PubMed ID: 2891555
[TBL] [Abstract][Full Text] [Related]
8. Effect of dopamine receptor activation on ganglionic transmission and cyclic AMP levels in the stellate ganglia and renal arteries of the dog.
Sabouni MH; Alkadhi KA; Lokhandwala MF
J Pharmacol Exp Ther; 1987 Jan; 240(1):93-8. PubMed ID: 2879905
[TBL] [Abstract][Full Text] [Related]
9. Ganglionic dopamine receptors as mediators of the inhibition of neurogenic vasoconstriction produced by fenoldopam.
Lokhandwala MF; Sabouni MH
J Auton Pharmacol; 1985 Dec; 5(4):301-5. PubMed ID: 2869042
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the role of alpha-1 and alpha-2 adrenoceptors in the maintenance of neurogenic tone to the hindlimb vasculature.
Hamed AT; Jandhyala BS; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Aug; 238(2):599-605. PubMed ID: 3016243
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats.
Sengupta S; Lokhandwala MF
J Auton Pharmacol; 1985 Dec; 5(4):289-94. PubMed ID: 2869041
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
Hahn RA; Wardell JR; Sarau HM; Ridley PT
J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
[TBL] [Abstract][Full Text] [Related]
15. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
Ensinger H; Majewski H; Hedler L; Starke K
J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
[TBL] [Abstract][Full Text] [Related]
16. Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
Hahn RA; MacDonald BR
J Pharmacol Exp Ther; 1984 Sep; 230(3):558-68. PubMed ID: 6470973
[TBL] [Abstract][Full Text] [Related]
17. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs.
Barrett RJ; Lokhandwala MF
Eur J Pharmacol; 1983 Dec; 96(3-4):211-26. PubMed ID: 6676105
[TBL] [Abstract][Full Text] [Related]
18. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effects of SKF 82526 and LY 171555 on presynaptic (DA2) and postsynaptic (DA1) dopamine receptors in rat kidney.
Lokhandwala MF; Steenberg ML
J Auton Pharmacol; 1984 Dec; 4(4):273-7. PubMed ID: 6152269
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]